These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26095778)

  • 1. Molecular categorisation of gliomas.
    Burki TK
    Lancet Oncol; 2015 Jul; 16(7):e320. PubMed ID: 26095778
    [No Abstract]   [Full Text] [Related]  

  • 2. Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.
    Zhang Z; Chan AK; Ding X; Li Y; Zhang R; Chen L; Liu Y; Wang Y; Xiong J; Ng HK; Yao Y; Zhou L
    Neuro Oncol; 2017 Jul; 19(7):1008-1010. PubMed ID: 28874004
    [No Abstract]   [Full Text] [Related]  

  • 3. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
    Wijnenga MMJ; Dubbink HJ; French PJ; Synhaeve NE; Dinjens WNM; Atmodimedjo PN; Kros JM; Dirven CMF; Vincent AJPE; van den Bent MJ
    Acta Neuropathol; 2017 Dec; 134(6):957-959. PubMed ID: 29052002
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4.
    Priesterbach-Ackley LP; Cordier F; de Witt Hamer P; Snijders TJ; Robe PA; Küsters B; de Leng WWJ; den Dunnen WFA; Brandsma D; Jansen C; Wesseling P; Muhlebner A
    Acta Neuropathol; 2024 Jul; 148(1):12. PubMed ID: 39073427
    [No Abstract]   [Full Text] [Related]  

  • 6. TERT promoter mutated WHO grades II and III gliomas are located preferentially in the frontal lobe and avoid the midline.
    Sun ZL; Chan AK; Chen LC; Tang C; Zhang ZY; Ding XJ; Wang Y; Sun CR; Ng HK; Yao Y; Zhou LF
    Int J Clin Exp Pathol; 2015; 8(9):11485-94. PubMed ID: 26617880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients.
    Qu CX; Ji HM; Shi XC; Bi H; Zhai LQ; Han DW
    Brain Behav; 2020 Apr; 10(4):e01583. PubMed ID: 32146731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification.
    Komori T
    Brain Tumor Pathol; 2020 Jan; 37(1):1-4. PubMed ID: 32060660
    [No Abstract]   [Full Text] [Related]  

  • 9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
    You H; Wu Y; Chang K; Shi X; Chen XD; Yan W; Li R
    CNS Neurosci Ther; 2017 Oct; 23(10):790-797. PubMed ID: 28868656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of isocitrate dehydrogenase-1/2 gene mutations in gliomas.
    Yu L; Qi ST; Li ZY
    Chin Med J (Engl); 2010 Dec; 123(24):3697-705. PubMed ID: 22166653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
    Li G; Wang Z; Zhang C; Liu X; Yang F; Sun L; Liang J; Hu H; Liu Y; You G; Bao Z; Zhang W; Wang Z; Jiang T
    Dis Markers; 2018; 2018():5975216. PubMed ID: 29887919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.
    Jha P; Suri V; Sharma V; Singh G; Sharma MC; Pathak P; Chosdol K; Jha P; Suri A; Mahapatra AK; Kale SS; Sarkar C
    Exp Mol Pathol; 2011 Aug; 91(1):385-93. PubMed ID: 21569770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Intraoperative Molecular Characterization of Glioma.
    Shankar GM; Francis JM; Rinne ML; Ramkissoon SH; Huang FW; Venteicher AS; Akama-Garren EH; Kang YJ; Lelic N; Kim JC; Brown LE; Charbonneau SK; Golby AJ; Sekhar Pedamallu C; Hoang MP; Sullivan RJ; Cherniack AD; Garraway LA; Stemmer-Rachamimov A; Reardon DA; Wen PY; Brastianos PK; Curry WT; Barker FG; Hahn WC; Nahed BV; Ligon KL; Louis DN; Cahill DP; Meyerson M
    JAMA Oncol; 2015 Aug; 1(5):662-7. PubMed ID: 26181761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
    Venteicher AS; Tirosh I; Hebert C; Yizhak K; Neftel C; Filbin MG; Hovestadt V; Escalante LE; Shaw ML; Rodman C; Gillespie SM; Dionne D; Luo CC; Ravichandran H; Mylvaganam R; Mount C; Onozato ML; Nahed BV; Wakimoto H; Curry WT; Iafrate AJ; Rivera MN; Frosch MP; Golub TR; Brastianos PK; Getz G; Patel AP; Monje M; Cahill DP; Rozenblatt-Rosen O; Louis DN; Bernstein BE; Regev A; Suvà ML
    Science; 2017 Mar; 355(6332):. PubMed ID: 28360267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Pathological Features of Paediatric High-Grade Gliomas.
    Blasco-Santana L; Colmenero I
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH1 and IDH2 mutations in gliomas.
    Ducray F; Marie Y; Sanson M
    N Engl J Med; 2009 May; 360(21):2248-9; author reply 2249. PubMed ID: 19469031
    [No Abstract]   [Full Text] [Related]  

  • 19. A feast of reviews about brain and pituitary tumor pathology.
    Louis DN
    Brain Tumor Pathol; 2018 Apr; 35(2):49-50. PubMed ID: 29666968
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.
    Miwa T; Hirose Y; Sasaki H; Ezaki T; Yoshida K; Kawase T
    Neurosurgery; 2011 Jan; 68(1):206-12. PubMed ID: 21099717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.